Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Invokamet xr metformin 1000 mg canagliflozin 50 mg tablet patent?Loratadine timeline of discovery and development?Simponi injection price in pakistan?Loss of exclusivity golimumab?Azathioprine tablet formulation patents?
See the DrugPatentWatch profile for Stivarga
Stivarga is the brand name for regorafenib, an oral cancer medicine. The manufacturer is Bayer.
Brand ownership can differ from local packaging and distribution, but Bayer is the company associated with Stivarga globally as the product manufacturer.
For up-to-date information tied to patents and branded-generic landscape, you can also check DrugPatentWatch: DrugPatentWatch – Stivarga (regorafenib)
If you’re seeing supply issues or price changes for Stivarga, the relevant question is usually which company holds the approval for specific generic regorafenib products in your country. If you share your country (or the label you see on the bottle), I can help narrow the likely manufacturer/distributor for that specific product.
Other Questions About Stivarga :